[go: up one dir, main page]

LT3353175T - Monobaktamo antibiotiko druskos ir kietos formos - Google Patents

Monobaktamo antibiotiko druskos ir kietos formos

Info

Publication number
LT3353175T
LT3353175T LTEP16848099.4T LT16848099T LT3353175T LT 3353175 T LT3353175 T LT 3353175T LT 16848099 T LT16848099 T LT 16848099T LT 3353175 T LT3353175 T LT 3353175T
Authority
LT
Lithuania
Prior art keywords
salts
solid forms
monobactam antibiotic
monobactam
antibiotic
Prior art date
Application number
LTEP16848099.4T
Other languages
English (en)
Inventor
Eric Aubin
Andreas Fisch
Michael Mutz
Bernd Ulrich Riebesehl
Marc SCHOENHENTZ
Anthony Casarez
Zaixing LI
Mika Lindvall
Heinz Ernst Moser
Folkert Reck
Vijay SETHURAMAN
Robert Lowell Simmons
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LT3353175T publication Critical patent/LT3353175T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LTEP16848099.4T 2015-09-23 2016-09-20 Monobaktamo antibiotiko druskos ir kietos formos LT3353175T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562222430P 2015-09-23 2015-09-23
PCT/CN2016/099482 WO2017050218A1 (en) 2015-09-23 2016-09-20 Salts and solid forms of monobactam antibiotic

Publications (1)

Publication Number Publication Date
LT3353175T true LT3353175T (lt) 2020-10-12

Family

ID=58385723

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16848099.4T LT3353175T (lt) 2015-09-23 2016-09-20 Monobaktamo antibiotiko druskos ir kietos formos

Country Status (26)

Country Link
US (1) US10919887B2 (lt)
EP (1) EP3353175B1 (lt)
JP (1) JP6837480B2 (lt)
KR (1) KR102749337B1 (lt)
CN (1) CN108137573B (lt)
AU (1) AU2016327264B2 (lt)
CA (1) CA2999794C (lt)
CL (2) CL2018000745A1 (lt)
CY (1) CY1123509T1 (lt)
DK (1) DK3353175T3 (lt)
EA (2) EA037569B1 (lt)
ES (1) ES2817537T3 (lt)
HR (1) HRP20201423T1 (lt)
HU (1) HUE050849T2 (lt)
IL (1) IL258254B (lt)
LT (1) LT3353175T (lt)
MA (1) MA42946B1 (lt)
MX (1) MX377532B (lt)
PH (1) PH12018500653B1 (lt)
PL (1) PL3353175T3 (lt)
PT (1) PT3353175T (lt)
RS (1) RS60805B1 (lt)
RU (1) RU2754180C2 (lt)
SI (1) SI3353175T1 (lt)
SM (1) SMT202000480T1 (lt)
WO (1) WO2017050218A1 (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7235718B2 (ja) * 2017-08-02 2023-03-08 ノバルティス アーゲー モノバクタム系抗生物質およびその中間体を製造するための化学的方法
JP7120516B2 (ja) * 2017-08-16 2022-08-17 エルジー・ケム・リミテッド Zif系粉末を含む白色顔料、高分子樹脂フィルムおよび白色顔料を使用して媒質の色を変更する方法
WO2019092180A1 (en) * 2017-11-10 2019-05-16 Novartis Ag Administration of monobactam for the treatment of urinary tract infection
EP3747883A4 (en) 2018-01-29 2020-12-16 Medshine Discovery Inc. B-LACTAM MONOCYCLIC COMPOUND FOR TREATMENT OF BACTERIAL INFECTION
CN113227088B (zh) * 2018-12-18 2022-05-31 南京明德新药研发有限公司 单环β-内酰胺化合物在制药中的应用
US12516049B2 (en) 2019-11-22 2026-01-06 Suzhou Erye Pharmaceutical Co., Ltd Sulfonylurea ring substituted monocyclic β-lactam antibiotics
EP4079305A4 (en) 2019-12-19 2024-01-10 Shenzhen Optimum Biological Technology Co., Ltd APPLICATION OF A COMPOUND IN THE PREPARATION OF DRUG
CN113754651B (zh) 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN114728953B (zh) * 2020-08-06 2024-04-09 宁夏农林科学院 β-内酰胺类化合物,及其制备方法以及其作为抗菌素的应用
WO2022185240A1 (en) 2021-03-04 2022-09-09 Bp Asset Vi, Inc. Formulation of a monobactam antibiotic
WO2022185241A1 (en) 2021-03-04 2022-09-09 Bp Asset Vi, Inc. Process for manufacturing a monobactam antibiotic
CN115304594B (zh) * 2022-10-12 2023-02-14 苏州二叶制药有限公司 磺酰脲环取代的化合物的盐型及其晶型

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196202A (en) 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
EP0048953B1 (en) 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-lactam antibiotics
US4775670A (en) 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
WO1982001873A1 (en) 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4782147A (en) 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
CA1262128A (en) 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
IL67451A (en) 1981-12-25 1987-10-20 Takeda Chemical Industries Ltd 4-cyano-2-azetidinones and production thereof and process for the preparation of 4-carbamoyl-2-azetidinones using them
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
KR900005112B1 (ko) 1982-05-31 1990-07-19 반유세이야꾸 가부시끼가이샤 2-옥소-1-아제티딘술폰산 유도체의 제조방법
EP0096297B1 (de) 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
JPS6153282A (ja) 1984-08-22 1986-03-17 Banyu Pharmaceut Co Ltd 単環β−ラクタム誘導体
JPS6153283A (ja) 1984-08-24 1986-03-17 Banyu Pharmaceut Co Ltd 2−オキソ−1−アゼチジンスルホン酸誘導体
US4610824A (en) 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US5112968A (en) 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
PT2960244T (pt) 2008-10-31 2016-11-02 Shionogi & Co Cefalosporina contendo grupo catecol
CN102325769A (zh) 2008-12-19 2012-01-18 美国辉瑞有限公司 单卡波姆
ES2542431T3 (es) * 2010-11-29 2015-08-05 Pfizer Inc Monobactamas
UY34585A (es) * 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103044416A (zh) 2012-12-17 2013-04-17 浙江华方药业有限责任公司 一种卡芦莫南钠的合成方法
US20160326157A1 (en) 2014-01-06 2016-11-10 President And Fellows Of Harvard College Monobactams and methods of their synthesis and use
JP6153674B2 (ja) * 2014-03-24 2017-06-28 ノバルティス アーゲー 細菌感染を治療するためのモノバクタム有機化合物

Also Published As

Publication number Publication date
BR112018005805A2 (pt) 2018-10-16
HRP20201423T1 (hr) 2020-12-11
MX377532B (es) 2025-03-10
CL2018000745A1 (es) 2018-06-22
AU2016327264A1 (en) 2018-05-10
AU2016327264B2 (en) 2019-06-27
PL3353175T3 (pl) 2021-02-22
KR20180054816A (ko) 2018-05-24
WO2017050218A1 (en) 2017-03-30
SI3353175T1 (sl) 2020-11-30
MA42946A (fr) 2018-08-01
PH12018500653B1 (en) 2022-05-04
PT3353175T (pt) 2020-09-10
US20180273522A1 (en) 2018-09-27
EP3353175B1 (en) 2020-08-12
CA2999794C (en) 2023-08-15
HUE050849T2 (hu) 2021-01-28
EP3353175A1 (en) 2018-08-01
RU2018114480A (ru) 2019-10-23
RS60805B1 (sr) 2020-10-30
SMT202000480T1 (it) 2020-11-10
CN108137573B (zh) 2021-06-11
JP2018528241A (ja) 2018-09-27
JP6837480B2 (ja) 2021-03-03
HK1257271A1 (en) 2019-10-18
IL258254B (en) 2021-02-28
KR102749337B1 (ko) 2025-01-03
US10919887B2 (en) 2021-02-16
EP3353175A4 (en) 2019-06-26
MX2018003592A (es) 2018-06-18
CN108137573A (zh) 2018-06-08
CL2019003324A1 (es) 2020-04-17
MA42946B1 (fr) 2020-10-28
CY1123509T1 (el) 2022-03-24
EA201890771A1 (ru) 2018-09-28
ES2817537T3 (es) 2021-04-07
RU2018114480A3 (lt) 2020-06-09
CA2999794A1 (en) 2017-03-30
DK3353175T3 (da) 2020-09-14
PH12018500653A1 (en) 2018-10-01
RU2754180C2 (ru) 2021-08-30
EA037569B1 (ru) 2021-04-15
EA202092620A1 (ru) 2021-06-30
IL258254A (en) 2018-05-31

Similar Documents

Publication Publication Date Title
LT3353175T (lt) Monobaktamo antibiotiko druskos ir kietos formos
IL255006A0 (en) Bromodomain inhibitors
ZA201608847B (en) Beta-lactamase inhibitors
SG11201803408PA (en) Valbenazine salts and polymorphs thereof
IL250642B (en) glycosidase inhibitors
IL251784A0 (en) Bromodomain inhibitors
SG11201706729SA (en) Derivatives of sobetirome
IL259796A (en) Aza-benzimidazole inhibitors of pad4
IL268048A (en) Preparation salts and compounds of 1-methyl-d-tryptophan
EP3107540A4 (en) Polymorphs of lomitapide and its salts
IL252269A0 (en) History of benzothiazole antibacterials
SI3430004T1 (sl) Trdne oblike soli nilotiniba
HUP1600030A2 (en) Baricitinib salts
ZA201608331B (en) Aminoester derivatives
PT3250203T (pt) Composição para utilização crónica como composto para ganho de peso
ZA201607107B (en) Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound
HUP1500506A2 (en) Salts of palbociclib
SG11201708527RA (en) Manufacture of organopolysulfides and salts thereof
GB201621771D0 (en) New salts of compounds and uses thereof
HK1260336A1 (en) Valbenazine salts and polymorphs thereof
GB201515305D0 (en) Method of preventing a fall